Recent studies have shown that Api can inhibit the growth of BC cells and xenograft tumors both, in hormone receptor-positive BC [24,25,26,27] and in triple-negative breast cancer (TNBC) [28,29,30,31]. This evidence concerns the gene NR4A1 and breast cancer.